Skip to main content

Table 3 Data Assessment Schedule

From: A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention)

Data assessment Screening Baseline
Week 0
Dose adjustment 1
Week 2
Dose adjustment 2
Week 4
Dose adjustment 3
Week 8
On treatment
Week 26
Last dose
Week 52
Follow-up
Week 64
hCG-stimulation test x        
Blood pressure x x x x x x x x
Blood samples x x x x x x x x
Waist circumference   x     x x x
DXA scan   x     x x x
Oral glucose tolerance test   x     x x x
Questionnaires   x     x x x
Anogenital distance   x      x  
Randomization   x       
On treatment   x x x x x x  
Dose adjustment    x x x    
Evaluation of side effects   x x x x x x x